glp-1 discovery Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment GLP-1s are building a reputation

CagriSema The combination of OW SC GLP-1 RA semaglutide and non-selective amylin RA cagrilintide (AM833) has been shown to demonstrate an additive effect on glucose regulation and weight loss as both GLP-1 RA and amylin analogs act on glucagon secretion, delay gastric emptying and mediate weight loss by acting through both distinct and overlapping neural satiety and reward pathways [47, 121]

Structural Basis for GLP-1 Receptor Activation by LY3502970, an Orally Active Nonpeptide Agonist

Collectively, experimental data indicate that BPC-157 exerts coordinated effects on vascular dynamics, connective tissue remodeling, and cellular survival mechanisms

(Educational only not medical advice.)

GIP is another hormone that regulates glucose metabolism